Israel's Pluristem sees positive results from leg pain study

TEL AVIV (Reuters) - Israel's Pluristem Therapeutics Inc, a developer of placenta-based stem cell products, said on Tuesday it had positive results from a mid-stage study of its therapy to treat leg pain known as intermittent claudication (IC).
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news